Fear, anxiety and embarrassment stop women going for breast screening

November 9, 2011

(Medical Xpress) -- Fear, anxiety and embarrassment are some of the main barriers preventing women from going for breast screening, but this alone does not account for the variations in uptake, according to new work presented today at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool today.

Researchers from the Gateshead Foundation Trust looked at why breast screening uptake varies between different areas covered by their screening programme.

They found that even in areas of high deprivation – a known reason for low breast screening uptake – GP practices’ screening rates still differed by over 10 per cent.

By speaking to in focus groups they found that fear, anxiety and were the main reasons women gave for not attending breast screening. The other reason given was denial of the disease, saying cancer would never happen to them.

Further work also showed women were not aware that breast cancer risk increases with age. And – worryingly – most women could only name two symptoms* of the disease.

Julie Tucker, lead author from the Gateshead Foundation Trust, said: “Our results show that more must be done to tackle the low uptake of screening and poor awareness of breast cancer symptoms. We must ensure that GPs, nurses and health professionals feel able to talk to women about the pros and cons of breast screening as well as what signs and symptoms they need to look out for.

“We also need to dispel some of the myths around breast cancer – it’s not a death sentence and more women are surviving this disease than ever before. This in turn will reduce women’s fear of the disease. The earlier breast cancer is diagnosed, the better the chance of survival so women shouldn’t be afraid of going to the doctor with symptoms or going for regular mammograms.”

Dr Jane Cope, director of the NCRI, said: “This is important research to help understand what is putting off some women going for . Every year over 48,000 women are diagnosed with and around 12,000 die from the disease.”

Explore further: Breast cancer patients lack adequate fertility preservation advice

More information: *Symptoms include a lump or thickening in an area of the breast; change in the size or shape of the breast; dimpling of the skin; a change in the shape of the nipple, particularly if it turns in, sinks into the breast or becomes irregular in shape; blood stained discharge from the nipple; a rash on the nipple or surrounding area; swelling or lump in the armpit.

Related Stories

Breast cancer patients lack adequate fertility preservation advice

November 7, 2011
(Medical Xpress) -- Women may not receive adequate information on fertility preservation before breast cancer treatment, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in ...

Researcher calls for mammograms to be tailored to patient

September 30, 2011
Mammograms are not one-size-fits-all, says noted breast cancer researcher Karla Kerlikowske, MD, of the University of California, San Francisco (UCSF). Rather, they should be customized based on a woman’s age, breast ...

Heart disease beats breast cancer as the biggest killer

June 19, 2011
Breast cancer accounts for almost a third of all cancer cases reported in women. However advances in the treatment for breast cancer, and early detection, have improved the chances of survival from the disease. New research ...

Recommended for you

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Combining CAR T cells with existing immunotherapies may overcome resistance in glioblastomas

July 19, 2017
Genetically modified "hunter" T cells successfully migrated to and penetrated a deadly type of brain tumor known as glioblastoma (GBM) in a clinical trial of the new therapy, but the cells triggered an immunosuppressive tumor ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.